[
    [
        {
            "time": "",
            "original_text": "安图生物：抗体抗原等原材料对外销售业务尚在起步阶段",
            "features": {
                "keywords": [
                    "安图生物",
                    "抗体抗原",
                    "原材料",
                    "对外销售",
                    "起步阶段"
                ],
                "sentiment_score": 0.2,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技",
                    "医疗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "安图生物：抗体抗原等原材料对外销售业务尚在起步阶段",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "安图生物：目前公司拥有国家级创新平台2个，创新平台申报工作尚在进行中",
            "features": {
                "keywords": [
                    "安图生物",
                    "国家级创新平台",
                    "创新平台申报",
                    "进行中"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技",
                    "研发"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "安图生物：目前公司拥有国家级创新平台2个，创新平台申报工作尚在进行中",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "净赚约3489万欧元 安图生物出售参股公司芬兰Mobidiag Oy股权",
            "features": {
                "keywords": [
                    "安图生物",
                    "芬兰Mobidiag Oy",
                    "股权出售",
                    "净赚",
                    "3489万欧元"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "国际合作"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "净赚约3489万欧元 安图生物出售参股公司芬兰Mobidiag Oy股权",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]